AI Verdict
INNI has stronger fundamentals based on our AI analysis.
INO vs INNI Fundamental Comparison
| Metric | INO | INNI |
|---|---|---|
| Revenue | $65,343.0 | $414,189.0 |
| Net Income | $-84.9M | $-2.4M |
| Net Margin | -130,000.0% | -581.3% |
| ROE | -352.5% | N/A |
| ROA | -114.3% | -37.2% |
| Current Ratio | 1.40x | 0.20x |
| Debt/Equity | 2.60x | N/A |
| EPS | $-1.81 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
INO vs INNI: Frequently Asked Questions
Is INO or INNI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INNI has stronger fundamentals. INO is rated STRONG SELL (92% confidence) while INNI is rated STRONG SELL (95% confidence). This is not investment advice.
How does INO compare to INNI fundamentally?
INOVIO PHARMACEUTICALS, INC. has ROE of -352.5% vs Innovaro, Inc.'s N/A. Net margins are -130,000.0% vs -581.3% respectively.
Which stock pays higher dividends, INO or INNI?
INO has a dividend yield of N/A or no dividend while INNI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in INO or INNI for long term?
For long-term investing, consider that INO has STRONG SELL rating with 92% confidence, while INNI has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about INO vs INNI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For INO vs INNI, the AI consensus favors INNI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.